The cannabis company Weekend Unlimited Inc (CSE:YOLO) announced Thursday that R&D Pharma, its acquisition target in Jamaica, is expanding its marijuana growing operations.
An additional five-acre outdoor plot at the R&D Pharma property in Jamaica is set to be prepared for cultivation beginning next year, which should triple the company’s production.
And Cody Corrubia, CEO of Weekend Unlimited, reports that 37 additional cannabis strains are being cultivated and ‘phenotyped’ by the Jamaican company as part of an in-depth program to produce unique equatorial and tropical cannabis varieties for both the medical and recreational markets.
Called Tropicann Jamaica, the R&D Pharma property now spans 98 acres, 60 acres of which are usable for cultivation.
The Jamaican company is now producing 13 acclimated strains of cannabis and 120 mother plants, according to Corrubia.
Currently, there are 5.2 acres of terraced outdoor cultivation being used at the site. This includes 3.2 acres of commercial cultivation, which is capable of producing 5,750kg of dry material per year. The remaining two acres are used for research and development, producing 3,000kg.
The site also boasts a 6,000 square foot green house, which houses a 3,600 square foot flower room; this facility is able to produce 600 kg of dry material per year for an onsite dispensary, which is planned to serve tourists.
Weekend Unlimited shares slipped 4.35% to hit C$0.11 on Wednesday.
Contact Ellen Kelleher at [email protected]